vimarsana.com

Page 226 - ஆரோக்கியம் பராமரிப்பு ஆம்ப் மருத்துவமனைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Perception Health Debuts Monthly Executive Report, Combining Extraordinary Analytics With Comprehensive Data Sets

Perception Health Debuts Monthly Executive Report, Combining Extraordinary Analytics With Comprehensive Data Sets Monthly Executive Reports Provide Actionable Insights for Operational Growth News provided by Share this article Share this article NASHVILLE, Tenn., Jan. 14, 2021 /PRNewswire/  Perception Health, a leading provider of healthcare market prediction software, announced today the national rollout of Monthly Executive Reports. Our team of healthcare data experts has culled out the most impactful metrics for the health industry by local markets, said J. Tod Fetherling, Chief Executive Officer, Perception Health. Our goal is to bring our expertise to all executives to assist in taking bold actions based on fresh market insights.

Logan University Introduces Master s in Athletic Training Program

Logan University Introduces Master s in Athletic Training Program Program Prepares Athletic Trainers to Provide Evidence-Based Health Care for Active People News provided by Share this article Share this article ST. LOUIS, Jan. 14, 2021 /PRNewswire/  Active people need health care providers that truly understand the demands of physical performance, and as such, Logan University will launch a Master s in Athletic Training to its lineup of degree programs, beginning fall 2021. Logan s reputation as a leader in chiropractic and health sciences education sets the stage for this new master s degree, featuring hands-on clinical experience earned in a wide variety of settings, said Logan University President Clay McDonald, DC ( 82), MBA, JD. We re proud to continue growing our University offerings with innovative, in-demand programs and evidence-based curricula.

AcelRx Announces Year-End 2020 Metrics and Review of 2020 Achievements

Share this article Share this article REDWOOD CITY, Calif., Jan. 14, 2021 /PRNewswire/  AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced preliminary unaudited financial results and other information in connection with its participation in investor presentations, meetings and events during the week of the 39 th Annual J.P. Morgan Healthcare Conference. The Company will post its revised corporate presentation in the investor section of its website. Key Highlights of 2020 DSUVIA® achieved Milestone C approval from the Department of Defense (DoD), a decision that approves DSUVIA for use in all U.S. Army sets, kits and outfits (SKOs). Initial stocking orders have begun for U.S. Army SKOs and are expected to approximate $30 million over the next three years, dependent on troop deployment schedules.

Medical Tourism Market to Reach $273 72 Bn, Globally, by 2027 at 12 8% CAGR: Says Allied Market Research

Share this article Share this article Affordable good quality care, accessible information and care, and support from government agencies and associations fuel the growth of the global medical tourism market. PORTLAND, Ore., Jan. 14, 2021 /PRNewswire/ Allied Market Research published a report, titled, by Treatment Type (Dental Treatment, Cosmetic Treatment, Cardiovascular Treatment, Orthopedic Treatment, Neurological Treatment, Cancer Treatment, Fertility Treatment, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2027. According to the report, the global medical tourism market was pegged at $104.68 billion in 2019 and is anticipated to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2020 to 2027. Key determinants of the market- Affordable good quality care, accessible information and care, and support from government agencies and associations fuel the growth of the global medical tourism market. On the other hand, limited coverage, le

PRIME® Study on Real-World Racial Disparities in Multiple Myeloma Care Wins Prestigious William Campbell Felch Award

Share this article Share this article The award-winning implementation science program focuses on health equity in relapsed/refractory multiple myeloma, which aligns with the American Society of Clinical Oncology new recommendations urging stakeholders to address structural barriers responsible for disparate cancer outcomes. Support for the award-winning project was provided to PRIME through educational grants from AbbVie, Inc. and Celgene Corporation / Bristol-Myers Squibb. With this program, PRIME sets a new industry standard for equity-focused implementation science initiatives, offering the wider CE community a framework for conducting racial disparities projects. PRIME developed a multicomponent initiative to assess and address the root causes of racial disparities in care delivery among patients with relapsed/refractory multiple myeloma at two health systems, a large public hospital system and an academic medical center. In the study, more than 1 in 5 patients reported th

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.